Tablets of almotriptan malate, a selective serotonin receptor agonist, used in migraine therapy. Produced by API suppliers and formulators for B2B sup...

Non-nucleoside reverse transcriptase inhibitor in tablet form, utilized in certain off-label antimigraine regimens despite primary antiretroviral role...

Bioequivalent versions of branded antimigraine medications, including triptans and ergotamines, produced by generic manufacturers. Supplied to pharmac...

Combination tablet integrating NSAID with antiemetic component, targeted at gastrointestinal-tolerant pain management in inflammatory states. Manufact...

Second-generation triptan in oral tablet dosage for prolonged migraine attack mitigation. Supplied to primary care and headache clinics by internation...

Calcium channel blocker in intravenous solution for cerebral vasospasm prevention post-subarachnoid hemorrhage, applied in antimigraine contexts. Acqu...

Oral calcium antagonist formulation for neuroprotection in migraine-associated vascular conditions. Purchased by hospital formularies and community ph...

Oral tablet formulations of 5-HT1B/1D receptor agonists for acute migraine attacks, produced by pharmaceutical companies, distributed to primary care ...

Anticonvulsant agent in injectable suspension for prophylactic migraine control in refractory cases. Supplied to emergency departments and neurology w...

Selective serotonin 5-HT1B/1D receptor agonist in solid oral form for abortive migraine treatment. Distributed to outpatient clinics and retail pharma...

Oral capsules containing tolfenamic acid, a non-steroidal anti-inflammatory agent, formulated for acute migraine relief. Manufactured by pharmaceutica...

Triptan-class intranasal formulation targeting serotonin receptors for rapid migraine relief. Procured by specialty pharmacies and ambulatory care fac...